Concepedia

Leah J. Hogdal

LJ

17

Publications

3.1K

Citations

17

H-Index

2010

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

The University of Texas MD Anderson Cancer Center

Harvard University

AbbVie (United States)

Oregon Health & Science University

Leah J. Hogdal is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and oncology.

Top concepts

Publications per year

2010–2024

17

Publications

17

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

Marina Konopleva, Daniel A. Pollyea, Jalaja Potluri et al. · Cancer Discovery · 2016 · 1K citations · Full text

Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

Rongqing Pan, Leah J. Hogdal, Juliana M. Benito et al. · Cancer Discovery · 2013 · 717 citations · Full text

A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia

Haley E. Ramsey, Melissa A. Fischer, Taekyu Lee et al. · Cancer Discovery · 2018 · 355 citations · Full text

Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax

Joan Montero, Jason Stephansky, Tianyu Cai et al. · Cancer Discovery · 2016 · 205 citations · Full text

MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199

Juliana M. Benito, Laura Godfrey, Kensuke Kojima et al. · Cell Reports · 2015 · 152 citations · Full text

, , +15

Rows per page

1–5 of 17